Humco Calagesic

Humco Calagesic is an FDA drug label for the active ingredient CALAMINE AND PRAMOXINE HYDROCHLORIDE manufactured by Pharma Nobis, LLC administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231226.

Generic: CALAMINE AND PRAMOXINE HYDROCHLORIDE

Manufacturer: Pharma Nobis, LLC

Product Type: HUMAN OTC DRUG

Route: TOPICAL

Dosage Form:

NDC: 82645-922

Application: M016

Effective: 20231226

Active Ingredients: Active Ingredients Calamine 8% Pramoxine HCl 1%

Indications & Usage

Uses Dries the oozing and weeping, and temporarily relieves pain and itching of poison ivy, oak, and sumac or other skin irritations.

Dosage & Administration

Directions Adults and children 2 yr. of age and older. Shake well before using. Cleanse the skin with soap and water and let dry. Apply to the affected area using cotton or soft cloth, not more than 3 to 4 times daily as needed for comfort. Children under 2 yrs. of age. Consult a doctor before use.

Contraindications

Not available.

Warnings

Warnings For external use only. Use only as directed. When using this product. Avoid contact with eyes and moucous membranes.

Adverse Reactions